Selected research
Market Structure
Global Glucuronolactone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Glucuronolactone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Glucuronolactone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Glucuronolactone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Glucuronolactone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Glucuronolactone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Glucuronolactone include Suzhou Pharmaceutical Group, Shaoxing Marina Biotechnology, Hubei Yitai Pharmaceutical, Anhui Fubore Pharmaceutical & Chemical, Shouguang Zhonghe Biochemical, Merck Millipore, Foodchem International, Creative Compounds and Ceto Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Glucuronolactone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Glucuronolactone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Glucuronolactone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucuronolactone market size, projected growth trends, production technologies, key applications, and end-use industries.
Glucuronolactone Segment by Company
Suzhou Pharmaceutical Group
Shaoxing Marina Biotechnology
Hubei Yitai Pharmaceutical
Anhui Fubore Pharmaceutical & Chemical
Shouguang Zhonghe Biochemical
Merck Millipore
Foodchem International
Creative Compounds
Ceto Corporation
Glucuronolactone Segment by Type
Medical
Food
Glucuronolactone Segment by Application
Pharmaceuticals
Food & Beverage
Glucuronolactone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucuronolactone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucuronolactone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucuronolactone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Glucuronolactone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glucuronolactone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glucuronolactone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Glucuronolactone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Medical
- Food
Applications
- Pharmaceuticals
- Food & Beverage
Companies covered
- Suzhou Pharmaceutical Group
- Shaoxing Marina Biotechnology
- Hubei Yitai Pharmaceutical
- Anhui Fubore Pharmaceutical & Chemical
- Shouguang Zhonghe Biochemical
- Merck Millipore
- Foodchem International
- Creative Compounds
- Ceto Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Glucuronolactone Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Glucuronolactone Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Glucuronolactone Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Glucuronolactone Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Glucuronolactone Market Dynamics
- 2.1 Glucuronolactone Industry Trends
- 2.2 Glucuronolactone Industry Drivers
- 2.3 Glucuronolactone Industry Opportunities and Challenges
- 2.4 Glucuronolactone Industry Restraints
3 Glucuronolactone Market by Manufacturers
- 3.1 Global Glucuronolactone Revenue by Manufacturers (2021-2026)
- 3.2 Global Glucuronolactone Sales by Manufacturers (2021-2026)
- 3.3 Global Glucuronolactone Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Glucuronolactone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Glucuronolactone Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Glucuronolactone Manufacturers, Product Type & Application
- 3.7 Global Glucuronolactone Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Glucuronolactone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Glucuronolactone Players Market Share by Revenue in 2025
- 3.8.3 2025 Glucuronolactone Tier 1, Tier 2, and Tier 3
4 Glucuronolactone Market by Type
- 4.1 Glucuronolactone Type Introduction
- 4.1.1 Medical
- 4.1.2 Food
- 4.2 Global Glucuronolactone Sales by Type
- 4.2.1 Global Glucuronolactone Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Glucuronolactone Sales by Type (2021-2032)
- 4.2.3 Global Glucuronolactone Sales Market Share by Type (2021-2032)
- 4.3 Global Glucuronolactone Revenue by Type
- 4.3.1 Global Glucuronolactone Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Glucuronolactone Revenue by Type (2021-2032)
- 4.3.3 Global Glucuronolactone Revenue Market Share by Type (2021-2032)
5 Glucuronolactone Market by Application
- 5.1 Glucuronolactone Application Introduction
- 5.1.1 Pharmaceuticals
- 5.1.2 Food & Beverage
- 5.2 Global Glucuronolactone Sales by Application
- 5.2.1 Global Glucuronolactone Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Glucuronolactone Sales by Application (2021-2032)
- 5.2.3 Global Glucuronolactone Sales Market Share by Application (2021-2032)
- 5.3 Global Glucuronolactone Revenue by Application
- 5.3.1 Global Glucuronolactone Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Glucuronolactone Revenue by Application (2021-2032)
- 5.3.3 Global Glucuronolactone Revenue Market Share by Application (2021-2032)
6 Global Glucuronolactone Sales by Region
- 6.1 Global Glucuronolactone Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Glucuronolactone Sales by Region (2021-2032)
- 6.2.1 Global Glucuronolactone Sales by Region (2021-2026)
- 6.2.2 Global Glucuronolactone Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Glucuronolactone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Glucuronolactone Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Glucuronolactone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Glucuronolactone Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Glucuronolactone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Glucuronolactone Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Glucuronolactone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Glucuronolactone Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Glucuronolactone Revenue by Region
- 7.1 Global Glucuronolactone Revenue by Region
- 7.1.1 Global Glucuronolactone Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Glucuronolactone Revenue by Region (2021-2026)
- 7.1.3 Global Glucuronolactone Revenue by Region (2027-2032)
- 7.1.4 Global Glucuronolactone Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Glucuronolactone Revenue (2021-2032)
- 7.2.2 North America Glucuronolactone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Glucuronolactone Revenue (2021-2032)
- 7.3.2 Europe Glucuronolactone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Glucuronolactone Revenue (2021-2032)
- 7.4.2 Asia-Pacific Glucuronolactone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Glucuronolactone Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Glucuronolactone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Suzhou Pharmaceutical Group
- 8.1.1 Suzhou Pharmaceutical Group Company Information
- 8.1.2 Suzhou Pharmaceutical Group Business Overview
- 8.1.3 Suzhou Pharmaceutical Group Glucuronolactone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Suzhou Pharmaceutical Group Glucuronolactone Product Portfolio
- 8.1.5 Suzhou Pharmaceutical Group Recent Developments
- 8.2 Shaoxing Marina Biotechnology
- 8.2.1 Shaoxing Marina Biotechnology Company Information
- 8.2.2 Shaoxing Marina Biotechnology Business Overview
- 8.2.3 Shaoxing Marina Biotechnology Glucuronolactone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shaoxing Marina Biotechnology Glucuronolactone Product Portfolio
- 8.2.5 Shaoxing Marina Biotechnology Recent Developments
- 8.3 Hubei Yitai Pharmaceutical
- 8.3.1 Hubei Yitai Pharmaceutical Company Information
- 8.3.2 Hubei Yitai Pharmaceutical Business Overview
- 8.3.3 Hubei Yitai Pharmaceutical Glucuronolactone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hubei Yitai Pharmaceutical Glucuronolactone Product Portfolio
- 8.3.5 Hubei Yitai Pharmaceutical Recent Developments
- 8.4 Anhui Fubore Pharmaceutical & Chemical
- 8.4.1 Anhui Fubore Pharmaceutical & Chemical Company Information
- 8.4.2 Anhui Fubore Pharmaceutical & Chemical Business Overview
- 8.4.3 Anhui Fubore Pharmaceutical & Chemical Glucuronolactone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Anhui Fubore Pharmaceutical & Chemical Glucuronolactone Product Portfolio
- 8.4.5 Anhui Fubore Pharmaceutical & Chemical Recent Developments
- 8.5 Shouguang Zhonghe Biochemical
- 8.5.1 Shouguang Zhonghe Biochemical Company Information
- 8.5.2 Shouguang Zhonghe Biochemical Business Overview
- 8.5.3 Shouguang Zhonghe Biochemical Glucuronolactone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Shouguang Zhonghe Biochemical Glucuronolactone Product Portfolio
- 8.5.5 Shouguang Zhonghe Biochemical Recent Developments
- 8.6 Merck Millipore
- 8.6.1 Merck Millipore Company Information
- 8.6.2 Merck Millipore Business Overview
- 8.6.3 Merck Millipore Glucuronolactone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Merck Millipore Glucuronolactone Product Portfolio
- 8.6.5 Merck Millipore Recent Developments
- 8.7 Foodchem International
- 8.7.1 Foodchem International Company Information
- 8.7.2 Foodchem International Business Overview
- 8.7.3 Foodchem International Glucuronolactone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Foodchem International Glucuronolactone Product Portfolio
- 8.7.5 Foodchem International Recent Developments
- 8.8 Creative Compounds
- 8.8.1 Creative Compounds Company Information
- 8.8.2 Creative Compounds Business Overview
- 8.8.3 Creative Compounds Glucuronolactone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Creative Compounds Glucuronolactone Product Portfolio
- 8.8.5 Creative Compounds Recent Developments
- 8.9 Ceto Corporation
- 8.9.1 Ceto Corporation Company Information
- 8.9.2 Ceto Corporation Business Overview
- 8.9.3 Ceto Corporation Glucuronolactone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Ceto Corporation Glucuronolactone Product Portfolio
- 8.9.5 Ceto Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Glucuronolactone Value Chain Analysis
- 9.1.1 Glucuronolactone Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Glucuronolactone Production Mode & Process
- 9.2 Glucuronolactone Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Glucuronolactone Distributors
- 9.2.3 Glucuronolactone Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst